GAO report reveals flaws in data collection and oversight affecting community impact claims of coalitions.
The federal program supporting the formation and prevention activity of community anti‐drug coalitions has strong backing in Washington but continues to show flaws in data collection and oversight that compromise its claims of community impact, a new report from Congress's Government Accountability Office (GAO) states. Some of the report's conclusions resemble findings from past years' analyses of the Drug‐Free Communities (DFC) Support Program.
No takes yet. Share an insight, caveat, or question.
Gary Enos (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: